Low levels of cathepsin D are associated with a poor prognosis in endometrial cancer
Open Access
- 14 January 1999
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 79 (3-4) , 570-576
Abstract
Total cytosolic cathepsin D (Cat D) levels were estimated by an immunoradiometric assay in a series of 156 consecutive patients with surgical stages I–III primary endometrial adenocarcinoma. Simultaneously, the tissue content of both oestrogen (ER) and progesterone (PR) receptors, and p185HER-2/neu, DNA content (ploidy), and the fraction of S-phase cells (S-phase) were also estimated. Tumoral Cat D content ranged from 0 to 243 pmol mg–1 protein (median 44 pmol mg–1 protein) and was not associated with any of the established clinicopathological and biological prognostic variables, with the exception of a weak positive correlation with the tumoral p185HER-2/neu levels. Univariable analysis performed on a subset of 97 patients, followed for a minimum of 2 years or until death, showed that patient age at diagnosis, high histological grade, advanced surgical stage, vascular invasion, positive peritoneal cytology, low levels of Cat D, negative ER and PR status, aneuploidy, and high S-phase were predictive of the presence of persistent or recurrent disease. However, multivariable analysis revealed that only histological grade, surgical stage, Cat D and PR were significantly associated with the patient’s outcome. From these findings, we conclude that Cat D is an independent prognostic factor in endometrial adenocarcinoma, its low levels being associated with a worse clinical outcome.Keywords
This publication has 41 references indexed in Scilit:
- Significance of Cathepsin-D expression in uterine tumoursEuropean Journal of Cancer, 1995
- Relationship between cathepsin D and other pathological and biological parameters in 1752 patients with primary breast cancerEuropean Journal of Cancer, 1995
- Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic FactorsJNCI: Journal of the National Cancer Institute, 1994
- HER-2/neu expression: A major prognostic factor in endometrial cancerGynecologic Oncology, 1992
- Quality control of cathepsin-D measurement by the EORTC receptor study groupEuropean Journal of Cancer, 1992
- Cathepsin D and Prognosis in Breast CancerNew England Journal of Medicine, 1990
- CATHEPSIN D: AN INDEPENDENT PROGNOSTIC FACTOR FOR METASTASIS OF BREAST CANCERThe Lancet, 1989
- Purification and first characterization of the secreted and cellular 52-kDa proteins regulated by estrogens in human-breast cancer cellsEuropean Journal of Biochemistry, 1986
- The 52-kDa estrogen-induced protein secreted by MCF7 cells is a lysosomal acidic proteaseBiochemical and Biophysical Research Communications, 1986
- A secreted glycoprotein induced by estrogen in human breast cancer cell linesCell, 1980